What are the Outcomes Measured in Phase III Trials?
Phase III trials measure a range of outcomes to assess the treatment's effectiveness and safety. Common outcomes include overall survival, progression-free survival, response rate, and quality of life. Adverse events and side effects are also closely monitored. These outcomes help to determine whether the new treatment provides a significant improvement over the standard treatment.